Norleual
Norleual, an angiotensin (Ang) IV analog, is a hepatocyte growth factor (HGF) /c-Met inhibitor with an IC50 of 3 pM. Norleual is an AT4 receptor antagonist and exhibits potent antiangiogenic activities[1].
Product Specifications
CAS Number
334994-34-2
UNSPSC
12352209
Target
Angiotensin Receptor; c-Met/HGFR
Type
Peptides
Related Pathways
GPCR/G Protein; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/norleual.html
Solubility
10 mM in DMSO
Smiles
O=C(N(CCC1)[C@@H]1C(N[C@H](C(O)=O)CC2=CC=CC=C2)=O)[C@@H](NC[C@H](CC(C)C)NC([C@@H](NC([C@@H](N)CCCC)=O)CC(C=C3)=CC=C3O)=O)CC4=CN=CN4
Molecular Formula
C41H58N8O7
Molecular Weight
774.95
References & Citations
[1]B J Yamamoto, et al. The angiotensin IV analog Nle-Tyr-Leu-psi- (CH2-NH2) 3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. J Pharmacol Exp Ther. 2010 Apr;333 (1) :161-73.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC403374 20 µg
ERK5 (MAPK7) (NM_139032) Human Over-expression Lysate
Sign In for Pricing
View Details 
